Skip to main content

Rewriting the Heart Risk Equation for People With HIV

April 7, 2026
A new project led by Thibaut Davy-Mendez, PhD, MSPH, at the Institute for Global Health and Infectious Diseases, funded by the Gilead Research Scholars Program, is taking aim at a longstanding gap in HIV care: accurately predicting who is at highest risk for cardiovascular disease. Backed by a two-year award from Gilead, the study will...

Protection at the Prison Gate: A Long‑Acting HIV Prevention Study at Release

April 7, 2026
When people leave prison, they enter one of the highest-risk periods for acquiring HIV—often with the least support, the fewest resources, and the greatest uncertainty about where to turn for care. It’s this critical gap that Lina Rosengren, MD, MPH, an infectious diseases physician and researcher with the Institute for Global...

Fogarty Fellow Returns to Her Roots in Malawi

April 5, 2026
Laika Maganga, a PhD candidate at the School of Nursing and UJMT Fogarty Fellow, is doing her dissertation research in Malawi, drawing on her family roots while centering the lived experiences of young women to take on HIV stigma and support healthier futures.   How has your training and clinical work...

Socioeconomic and Environmental Drivers of Pediatric Malaria

March 30, 2026
Ashley Wade is a medical student at Icahn School of Medicine at Mount Sinai and is mentored by Ross Boyce, MD, MSc. In many parts of Sub‑Saharan Africa, malaria is still one of the main reasons children are hospitalized. In a recent study, Wade and Annika Gunderson, a UNC Epidemiology...

Courage, Conviction, Resolve: The Story of Dr. Gui Xi’en

March 30, 2026
“What struck me most about Dr. Gui wasn’t just what he accomplished, but how quietly he did it. He never framed his work as heroic. He saw suffering, understood the science, and felt responsible to act. Writing this essay was my way of preserving a story that could have been...

Tracking Respiratory Infections in People Living With HIV in Rural Uganda

March 19, 2026
Lauryn Ursery is a PhD student in epidemiology studying at the Gillings School of Global Public Health, mentored by Dr. Ross Boyce. In rural Western Uganda, people living with HIV face unique health risks, including viral acute respiratory infections (ARIs) such as the flu. Ursery presented a study led by...

Tracking Zika and Dengue: Insights into Maternal and Infant Immunity in Nicaragua

March 12, 2026
Omar Zepeda is a PhD student studying at the University of Costa Rica and a fellow of the Nicaraguan Emerging and Endemic Diseases (NEED) program. He is mentored by Filemon Bucardo, PhD. At the recent 4th Annual Global Health Symposium Zepeda presented his findings on the Zika and Dengue viruses...

China Scholars Highlight Advances in Digital Innovation and Sexual Health Research

March 11, 2026
At the Fourth Annual Global Health Scholars Symposium, three student researchers working in China showcased a forward‑looking portfolio of studies focused on digital health, HIV prevention, and community‑engaged sexual health interventions. Their work showed how technology, behavioral insights, and innovative service models can transform the landscape of HIV and STI...

Zambia Scholars Drive New Insights in Neurological Health

March 11, 2026
At this year’s Global Health Scholars Symposium, students and early‑career researchers showcased a powerful range of studies addressing urgent neurological and health systems challenges in Zambia. The event was sponsored by the Institute for Global Health and Infectious Diseases and the Gillings School of Global Public Health. Neurologist Monica Diaz,...

Vietnam Scholars Take Center Stage

March 11, 2026
A cohort of emerging global health research scholars are advancing HIV prevention, substance use, mental health, and implementation science. Presented at the 4th Annual Global Health Scholars Symposium on Feb. 13, their projects shed new light on how Vietnam’s health system is addressing intertwined epidemics—HIV, methamphetamine use, depression, alcohol‑related harm—and...

Exploring the Link Between Gold Mining and Malaria in Tanzania

March 11, 2026
Claudia Gaither is a PhD student in Epidemiology studying at the Gillings School of Global Public Health, mentored by Michael Emch, PhD. At the 4th Annual Global Health Scholars Symposium, Gaither talked about the relationship between malaria prevalence and proximity to mineral processing pits in northwestern Tanzania, where gold mining...

Real World Impact: Malawi Scholars at the Global Health Scholars Symposium

March 11, 2026
From infectious disease threats to rapidly shifting policy landscapes—the work of emerging global health scholars has never been more vital. Resilience is no longer just an aspiration; it is a defining requirement for researchers striving to strengthen health systems, protect vulnerable populations, and advance equity in places where resources are...

UNC Project-China Examines Factors Shaping Prosocial Behavior in Donation‑Based HIV/STI Interventions

March 5, 2026
A systematic review led by Dorian Ho (UNC BSPH-2025), and Joseph Tucker, co-director of UNC Project-China and a member of the UNC Institute for Global Health and Infectious Diseases, found that givers leveraged altruism, agency, and relationality with recipients to improve distribution and use of health services in their social...

Gay Leads New Frontier in HIV Cure Science 

March 4, 2026
Cindy Gay, MD, MPH, and David Margolis, MD, and the UNC HIV Cure Center have launched two ambitious studies that are poised to advance HIV Cure science closer to ending the epidemic. The first uses highly engineered antibody-like molecules to help the immune system find and clear HIV‑infected cells, uniting...

Undergraduate Cedra Ali Studies the Connection Between HIV and Headache Disorders

March 4, 2026
Cedra Ali, a senior Honors student in the Department of Psychology and Neuroscience, presented her research at the 4th Annual Global Health Scholars Symposium in February. She was the only undergraduate presenter at the event, which primarily featured doctoral trainees, postdoctoral fellows, and faculty researchers from all over the globe....

Case Study Highlights Critical Need for Third‑Trimester Syphilis Screening in Carceral Settings to Prevent Congenital Syphilis 

March 2, 2026
Chapel Hill, NC— A newly published case study in the Journal of Correctional Health Care urges immediate action to strengthen syphilis screening protocols for pregnant individuals in U.S. jails and prisons. Researchers at the Institute for Global Health and Infectious Diseases recently published “Syphilis Screening Among Pregnant Individuals in Carceral...

Resilience in Global Health: Inside UNC’s 4th Annual Global Health Scholars Symposium

February 27, 2026
The 4th Annual Global Health Scholars Symposium—sponsored by the Institute for Global Health and Infectious Diseases and the Gillings School of Global Public Health—opened February 13 recognizing the resilience of UNC’s global health programs and the enduring partnerships that withstand today’s challenging landscape. The event brought together trainees, faculty, and...

Sawyer Accelerates the Fight Against Childhood Malaria

February 27, 2026
Dr. Ross Boyce, a researcher with the UNC Institute for Global Health and Infectious Diseases, tested a military uniform treatment idea on wraps used to carry babies in many parts of Africa and South America. Would treating these baby wraps with permethrin protect babies in Uganda from malaria? The answer...

Key International Mpox Trial Finds No Clinical Benefit from Tecovirimat 

February 26, 2026
William A. Fischer II, MD, Director of Emerging Pathogens at UNC’s Institute for Global Health and Infectious Diseases and Joe Eron, MD, UNC Chief of Infectious Diseases and chair of the ACTG, co-authored a study that found tecovirimat used to treat mpox does not shorten time to lesion resolution, reduce...

Twice‑Yearly Injectable HIV Regime Treatment Demonstrates Strong Efficacy and Safety  

February 26, 2026
A trial led by Joe Eron, MD, a researcher with the UNC Institute for Global Health and Infectious Diseases, marks a significant milestone toward what could become the first complete long‑acting HIV regimen requiring dosing only twice per year. This new report is considered the first Phase 2 study to...